# Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer

> **NCT00374140** · PHASE2 · COMPLETED · sponsor: **Ahmad Tarhini** · enrollment: 40 (actual)

## Conditions studied

- Small Cell Lung Cancer

## Interventions

- **DRUG:** RAD001 (everolimus)

## Key facts

- **NCT ID:** NCT00374140
- **Lead sponsor:** Ahmad Tarhini
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2008-12
- **Final completion:** 2012-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00374140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00374140, "Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00374140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*